Sartorius Stedim Biotech Share Price
Equities
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 170.35 EUR | -2.63% |
|
-4.43% | -18.88% |
| 02-13 | Diary - Europe's STOXX 600 Corporate Earnings Week Ahead | RE |
| 02-06 | Sartorius Stedim Proposes Stable Dividend for 2025 |  |
| Capitalization | 17.02B 20.2B 15.53B 14.82B 27.52B 1,830B 28.59B 181B 71.69B 884B 75.76B 74.21B 3,088B | P/E ratio 2025 |
76.8x | P/E ratio 2026 * | 40.2x |
|---|---|---|---|---|---|
| Enterprise value | 19.11B 22.68B 17.43B 16.64B 30.89B 2,055B 32.1B 203B 80.49B 992B 85.07B 83.32B 3,468B | EV / Sales 2025 |
6.89x | EV / Sales 2026 * | 5.94x |
| Free-Float |
30.28% | Yield 2025 * |
0.47% | Yield 2026 * | 0.52% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | -2.66% | ||
| 1 week | -4.46% | ||
| Current month | -9.56% | ||
| 1 month | -19.86% | ||
| 3 months | -10.39% | ||
| 6 months | -4.00% | ||
| Current year | -18.90% |
| 1 week | 168.2 |  | 180.9 |
| 1 month | 168.2 | | 215.7 |
| Current year | 168.2 | | 224 |
| 1 year | 148.75 | | 224 |
| 3 years | 139.1 | | 342.6 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.1 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 50 | 27/03/2023 |
| Chief Tech/Sci/R&D Officer | 61 | 07/09/2011 | |
Petra Kirchhoff
IRC | Investor Relations Contact | 57 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 06/04/2015 | |
Susan Dexter
BRD | Director/Board Member | 69 | 06/04/2015 |
Lothar Kappich
BRD | Director/Board Member | 69 | 13/09/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.11% | 0.42% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.66% | -4.46% | -18.36% | -49.88% | 20.2B | |
| +1.09% | +1.67% | -13.73% | +5.03% | 196B | |
| -1.38% | -3.31% | +7.20% | +17.75% | 128B | |
| +2.78% | +0.44% | +48.72% | +127.21% | 70.19B | |
| -2.52% | +0.16% | +42.79% | +100.95% | 62.23B | |
| -1.08% | -16.25% | -21.76% | -27.78% | 50.08B | |
| -0.09% | -5.81% | - | - | 37.07B | |
| +7.59% | +0.07% | -21.39% | -41.73% | 26.95B | |
| +1.69% | -1.51% | +13.23% | +25.35% | 24.36B | |
| -5.05% | -8.22% | -32.10% | +0.53% | 19.4B | |
| Average | +0.04% | -0.00% | +0.51% | +17.49% | 63.4B | |
| Weighted average by Cap. | +0.18% | +0.45% | +3.31% | +26.08% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 2.97B 3.53B 2.71B 2.59B 4.8B 319B 4.99B 31.52B 12.51B 154B 13.23B 12.95B 539B | 3.2B 3.8B 2.92B 2.79B 5.17B 344B 5.37B 33.94B 13.47B 166B 14.24B 13.95B 580B |
| Net income | 314M 373M 287M 274M 508M 33.78B 528M 3.33B 1.32B 16.31B 1.4B 1.37B 57.01B | 423M 503M 386M 369M 685M 45.52B 711M 4.49B 1.78B 21.98B 1.88B 1.85B 76.83B |
| Net Debt | 2.09B 2.48B 1.91B 1.82B 3.38B 225B 3.51B 22.18B 8.8B 109B 9.3B 9.11B 379B | 1.97B 2.34B 1.8B 1.72B 3.19B 212B 3.31B 20.92B 8.31B 102B 8.78B 8.6B 358B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/02/26 | 170.35 € | -2.63% | 15,339 |
| 13/02/26 | 174.95 € | +4.01% | 142,551 |
| 12/02/26 | 168.20 € | -3.08% | 84,345 |
| 11/02/26 | 173.55 € | -2.77% | 84,858 |
| 10/02/26 | 178.50 € | +0.14% | 94,037 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition